SST2-positive Neuroendocrine Neoplasms
1 clinical trials · Condition
◉ Watch SST2-positive Neuroendocrine Neoplasms
| Record | Firm | Date |
|---|---|---|
| A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors (NCT07129252) | Crinetics Pharmaceuticals Inc. | 2025-11-26 |
Track SST2-positive Neuroendocrine Neoplasms automatically
Every clearance here is in the API, with alerts when new ones post.